Phreesia (NYSE:PHR) Cut to Hold at Wall Street Zen

Wall Street Zen cut shares of Phreesia (NYSE:PHR) from a buy rating to a hold rating in a research report report published on Saturday morning.

Several other research firms have also commented on PHR. Weiss Ratings reiterated a “sell (e+)” rating on shares of Phreesia in a research note on Wednesday, January 28th. Citigroup reiterated a “neutral” rating and issued a $10.00 target price (down from $25.00) on shares of Phreesia in a research note on Tuesday, March 31st. Robert W. Baird reiterated a “neutral” rating and issued a $10.00 target price (down from $25.00) on shares of Phreesia in a research note on Tuesday, March 31st. Citizens Jmp reiterated a “market perform” rating on shares of Phreesia in a research note on Wednesday, April 1st. Finally, Wells Fargo & Company dropped their target price on Phreesia from $30.00 to $25.00 and set an “overweight” rating for the company in a research note on Thursday, March 26th. Twelve research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Phreesia currently has an average rating of “Moderate Buy” and an average target price of $22.00.

Phreesia Stock Performance

Phreesia stock opened at $9.10 on Friday. The firm has a market capitalization of $552.86 million, a P/E ratio of 303.30 and a beta of 0.86. The stock has a fifty day moving average price of $11.78 and a 200 day moving average price of $17.15. Phreesia has a 52 week low of $7.77 and a 52 week high of $32.76. The company has a current ratio of 1.53, a quick ratio of 2.44 and a debt-to-equity ratio of 0.41.

Phreesia (NYSE:PHR) last released its earnings results on Monday, March 30th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.05). The business had revenue of $127.07 million during the quarter, compared to analyst estimates of $126.75 million. Phreesia had a net margin of 0.48% and a return on equity of 3.23%. The business’s revenue for the quarter was up 15.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.11) earnings per share. Equities research analysts anticipate that Phreesia will post -1.1 earnings per share for the current year.

Insider Activity at Phreesia

In related news, SVP Amy Beth Vanduyn sold 2,202 shares of Phreesia stock in a transaction on Friday, January 16th. The shares were sold at an average price of $16.36, for a total transaction of $36,024.72. Following the transaction, the senior vice president owned 157,349 shares in the company, valued at approximately $2,574,229.64. The trade was a 1.38% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, General Counsel Allison C. Hoffman sold 6,176 shares of Phreesia stock in a transaction on Monday, March 23rd. The shares were sold at an average price of $11.97, for a total transaction of $73,926.72. Following the transaction, the general counsel owned 163,485 shares in the company, valued at $1,956,915.45. The trade was a 3.64% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 70,358 shares of company stock valued at $1,123,569 over the last three months. Insiders own 5.50% of the company’s stock.

Hedge Funds Weigh In On Phreesia

Several hedge funds and other institutional investors have recently made changes to their positions in PHR. Granahan Investment Management LLC grew its stake in shares of Phreesia by 73.8% in the fourth quarter. Granahan Investment Management LLC now owns 2,399,613 shares of the company’s stock valued at $40,601,000 after buying an additional 1,018,987 shares in the last quarter. Prosight Management LP acquired a new stake in shares of Phreesia in the fourth quarter valued at about $16,533,000. Millennium Management LLC grew its stake in shares of Phreesia by 730.7% in the third quarter. Millennium Management LLC now owns 1,064,132 shares of the company’s stock valued at $25,028,000 after buying an additional 936,033 shares in the last quarter. Jacobs Levy Equity Management Inc. acquired a new stake in shares of Phreesia in the fourth quarter valued at about $15,213,000. Finally, Greenhouse Funds LLLP grew its stake in shares of Phreesia by 16.8% in the third quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company’s stock valued at $91,317,000 after buying an additional 557,265 shares in the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.